130 related articles for article (PubMed ID: 3922441)
1. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
Simpson GM; Frederickson E; Palmer R; Pi E; Sloane RB; White K
Biol Psychiatry; 1985 Jun; 20(6):684-7. PubMed ID: 3922441
[No Abstract] [Full Text] [Related]
2. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
Murphy DL; Tamarkin L; Sunderland T; Garrick NA; Cohen RM
Psychiatry Res; 1986 Feb; 17(2):119-27. PubMed ID: 3008207
[TBL] [Abstract][Full Text] [Related]
3. Biochemical effects of L-deprenyl in atypical depressives.
Liebowitz MR; Karoum F; Quitkin FM; Davies SO; Schwartz D; Levitt M; Linnoila M
Biol Psychiatry; 1985 May; 20(5):558-65. PubMed ID: 3921065
[TBL] [Abstract][Full Text] [Related]
4. L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation.
Mendlewicz J; Youdim MB
Br J Psychiatry; 1983 May; 142():508-11. PubMed ID: 6409196
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonin response to treatment in geriatric depression.
McIntyre IM; Norman TR
Biol Psychiatry; 1989 Aug; 26(4):434-6. PubMed ID: 2765604
[No Abstract] [Full Text] [Related]
6. The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression.
Mann JJ; Frances A; Kaplan RD; Kocsis J; Peselow ED; Gershon S
J Clin Psychopharmacol; 1982 Feb; 2(1):54-7. PubMed ID: 6802883
[No Abstract] [Full Text] [Related]
7. L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.
Mann J; Gershon S
Life Sci; 1980 Mar; 26(11):877-82. PubMed ID: 6768943
[No Abstract] [Full Text] [Related]
8. Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy.
Lee DH; Mendoza M; Dvorozniak MT; Chung E; van Woert MH; Yahr MD
J Neural Transm Park Dis Dement Sect; 1989; 1(3):189-94. PubMed ID: 2505797
[TBL] [Abstract][Full Text] [Related]
9. Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
Tariot PN; Sunderland T; Cohen RM; Newhouse PA; Mueller EA; Murphy DL
J Clin Psychopharmacol; 1988 Feb; 8(1):23-7. PubMed ID: 3127432
[TBL] [Abstract][Full Text] [Related]
10. Dose regimen of deprenyl (selegiline) and platelet MAO activities.
Oreland L; Johansson F; Ekstedt J
Acta Neurol Scand Suppl; 1983; 95():87-9. PubMed ID: 6428150
[TBL] [Abstract][Full Text] [Related]
11. Effect of tranylcypromine stereoisomers on depressive syndromes.
Rüther E; Jungkunz G; Greil W; Zimmer R
Mod Probl Pharmacopsychiatry; 1983; 19():203-10. PubMed ID: 6865964
[No Abstract] [Full Text] [Related]
12. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
Georgotas A; Mann J; Friedman E
Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
[No Abstract] [Full Text] [Related]
13. The effect of isocarboxazid on platelet MAO activity.
Davidson J; White H
Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
[No Abstract] [Full Text] [Related]
14. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
15. l-Deprenyl in atypical depressives.
Quitkin FM; Liebowitz MR; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Markowitz J; Davies SO
Arch Gen Psychiatry; 1984 Aug; 41(8):777-81. PubMed ID: 6430257
[TBL] [Abstract][Full Text] [Related]
16. (-)Deprenyl in perspective: prophylaxis for Parkinson's disease?
Sandler M
J Neural Transm Suppl; 1986; 22():107-15. PubMed ID: 3097254
[TBL] [Abstract][Full Text] [Related]
17. Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
Emory H; Mizrahi N
J Diabetes Sci Technol; 2016 Sep; 10(5):1203-4. PubMed ID: 26961977
[No Abstract] [Full Text] [Related]
18. On the mode of action of L-deprenyl in the human central nervous system.
Riederer P; Youdim MB; Rausch WD; Birkmayer W; Jellinger K; Seemann D
J Neural Transm; 1978; 43(3-4):217-26. PubMed ID: 745014
[No Abstract] [Full Text] [Related]
19. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
20. A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor.
Mann JJ; Aarons SF; Wilner PJ; Keilp JG; Sweeney JA; Pearlstein T; Frances AJ; Kocsis JH; Brown RP
Arch Gen Psychiatry; 1989 Jan; 46(1):45-50. PubMed ID: 2491941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
